X
Xing Jiang Xie
Researcher at Sichuan University
Publications - 3
Citations - 386
Xing Jiang Xie is an academic researcher from Sichuan University. The author has contributed to research in topics: Antigen & Antibody. The author has an hindex of 3, co-authored 3 publications receiving 382 citations.
Papers
More filters
Journal ArticleDOI
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine
Yu Quan Wei,Qing Ru Wang,Xia Zhao,Li Yang,Ling Tian,You Lu,Bin Kang,Chong Jiu Lu,Mei Juan Huang,Yan Yan Lou,Fei Xiao,Qiu Ming He,Jing Mei Shu,Xing Jiang Xie,Yun Qiu Mao,Shong Lei,Feng Luo,Li Qun Zhou,Chong En Liu,Hao Zhou,Yu Jiang,Feng Peng,Liang Ping Yuan,Qiu Li,Yang Wu,Ji Yan Liu +25 more
TL;DR: It is shown that immunotherapy of tumors using fixed xenogeneic whole endothelial cells as a vaccine was effective in affording protection from tumor growth, inducing regression of established tumors and prolonging survival of tumor-bearing mice.
Journal ArticleDOI
Immunogene therapy of tumors with vaccine based on xenopus homologous vascular endothelial growth factor as a model antigen
Yu Quan Wei,Mei Juan Huang,Li Yang,Xia Zhao,Ling Tian,You Lu,Jing Mei Shu,Chong Jiu Lu,Ting Niu,Bin Kang,Yun Qiu Mao,Fen Liu,Yan Jun Wen,Shong Lei,Feng Luo,Li Qun Zhou,Feng Peng,Yu Jiang,Ji Yan Liu,Hao Zhou,Qing Ru Wang,Qiu Ming He,Fei Xiao,Yan Yan Lou,Xing Jiang Xie,Qiu Li,Yang Wu,Zhen Yu Ding,Bin Hu,Min Hu,Wei Zhang +30 more
TL;DR: It is found that immunogene tumor therapy with a vaccine based on XVEGF was effective at both protective and therapeutic antitumor immunity in several tumor models in mice, and may provide a vaccine strategy for cancer therapy through the induction of autoimmunity against the growth factors associated with tumor growth.
Journal ArticleDOI
Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3.
Yan Yan Lou,Yu Quan Wei,Li Yang,Xia Zhao,Ling Tian,You Lu,Yan Jun Wen,Fen Liu,Mei Juan Huang,Bin Kang,Fei Xiao,Jing Mei Su,Qu Ming He,Xing Jiang Xie,Yun Qiu Mao,Song Lei,Ji Yan Liu,Fen Lou,Li Qun Zhou,Feng Peng,Yu Jiang,Bing Hu +21 more
TL;DR: It is found that immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken integrin β3 (P-BD-C) was effective in both protective and therapeutic anti-tumor immunity in several tumor models in mice, providing a vaccine strategy for cancer therapy through the induction of the autoimmunity.